Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Fitzsimmons

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|May 5, 2022
COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse eventsWilliam E Fitzsimmons
Transplantation|June 16, 2023
Acute Rejection After Kidney Transplant-An Endpoint Not Predictive of Treatment Effect on Graft SurvivalWilliam E Fitzsimmons, Maarten Naesens
Therapeutic Innovation & Regulatory Science|October 23, 2020
Ensuring Black Lives Matter in Drug DevelopmentWilliam E Fitzsimmons, Clara Okorie-Awé
Yonsei Medical Journal|January 1, 2005
FK778, a synthetic malononitrilamideWilliam E Fitzsimmons, M Roy First
Yonsei Medical Journal|January 1, 2005
Modified release tacrolimusM Roy First, William E Fitzsimmons
Transplantation|June 18, 2004
New drugs to improve transplant outcomesM Roy First, William E Fitzsimmons
Therapeutic Innovation & Regulatory Science|October 23, 2023
Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug ApprovalsMuhammed Y Idris, William E Fitzsimmons, Priscilla Pemu
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2023
Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT studyAmanda Klein, Alice Toll, Darren Stewart, et al.
Pharmacological Reports : PR|September 9, 2016
Use of low-dose tacrolimus and associated hypomagnesemia in the prevention of erectile dysfunction following prostatectomy for prostate cancerMartin R First, Alice K Henning, William E Fitzsimmons
Biorxiv : the Preprint Server for Biology|February 16, 2022
In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antiviralsWilliam E Fitzsimmons, Tracy L Hartman, Michelle Mendenhall, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|May 5, 2022
COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse eventsWilliam E Fitzsimmons
Transplantation|June 16, 2023
Acute Rejection After Kidney Transplant-An Endpoint Not Predictive of Treatment Effect on Graft SurvivalWilliam E Fitzsimmons, Maarten Naesens
Therapeutic Innovation & Regulatory Science|October 23, 2020
Ensuring Black Lives Matter in Drug DevelopmentWilliam E Fitzsimmons, Clara Okorie-Awé
Yonsei Medical Journal|January 1, 2005
FK778, a synthetic malononitrilamideWilliam E Fitzsimmons, M Roy First
Yonsei Medical Journal|January 1, 2005
Modified release tacrolimusM Roy First, William E Fitzsimmons
Transplantation|June 18, 2004
New drugs to improve transplant outcomesM Roy First, William E Fitzsimmons
Therapeutic Innovation & Regulatory Science|October 23, 2023
Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug ApprovalsMuhammed Y Idris, William E Fitzsimmons, Priscilla Pemu
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2023
Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT studyAmanda Klein, Alice Toll, Darren Stewart, et al.
Pharmacological Reports : PR|September 9, 2016
Use of low-dose tacrolimus and associated hypomagnesemia in the prevention of erectile dysfunction following prostatectomy for prostate cancerMartin R First, Alice K Henning, William E Fitzsimmons
Biorxiv : the Preprint Server for Biology|February 16, 2022
In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antiviralsWilliam E Fitzsimmons, Tracy L Hartman, Michelle Mendenhall, et al.
Pageof 4